Integer Holdings Co. (NYSE:ITGR) Receives $145.44 Consensus Price Target from Brokerages

Integer Holdings Co. (NYSE:ITGR) has been assigned a consensus recommendation of “Moderate Buy” from the nine brokerages that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $145.44.

A number of brokerages have recently commented on ITGR. Bank of America increased their price objective on Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Tuesday, October 1st. Wells Fargo & Company reaffirmed an “overweight” rating and set a $160.00 target price on shares of Integer in a report on Tuesday, December 3rd. Truist Financial boosted their price objective on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Piper Sandler reiterated an “overweight” rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a report on Friday, October 25th. Finally, Benchmark boosted their price target on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, October 21st.

Integer Trading Down 0.3 %

Shares of ITGR stock opened at $132.17 on Friday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The stock has a 50-day simple moving average of $135.18 and a 200 day simple moving average of $127.12. Integer has a fifty-two week low of $94.56 and a fifty-two week high of $142.76. The stock has a market capitalization of $4.43 billion, a P/E ratio of 40.79, a P/E/G ratio of 2.02 and a beta of 1.12.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.59 million. During the same quarter in the previous year, the company posted $1.27 EPS. The business’s revenue was up 8.7% compared to the same quarter last year. On average, sell-side analysts expect that Integer will post 5.33 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Integer

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Contravisory Investment Management Inc. raised its stake in shares of Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares in the last quarter. Huntington National Bank raised its position in Integer by 8,933.3% during the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 268 shares in the last quarter. Quest Partners LLC lifted its stake in Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 332 shares during the last quarter. GAMMA Investing LLC grew its position in Integer by 74.1% in the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock worth $85,000 after acquiring an additional 278 shares in the last quarter. Finally, Larson Financial Group LLC increased its stake in shares of Integer by 20,000.0% during the 3rd quarter. Larson Financial Group LLC now owns 1,005 shares of the medical equipment provider’s stock worth $131,000 after purchasing an additional 1,000 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.